LLY - Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector | Benzinga
In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Eli Lilly and Co (NYSE:LLY) in relation to its major competitors in the Pharmaceuticals industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company's performance in the industry.
Eli Lilly and Co Background
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
| Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Co | |||||||
| 133.88 | |||||||
| 63.88 | |||||||
| 22.86 | |||||||
| 19.02% | |||||||
| $3.12 | |||||||
| $7.09 | |||||||
| 25.98% | |||||||
| Novo Nordisk A/S | |||||||
| 50.55 | |||||||
| 45.32 | |||||||
| 18.48 | |||||||
| 24.73% | |||||||
| $36.91 | |||||||
| $55.43 | |||||||
| 22.45% | |||||||
| Johnson & Johnson | |||||||
| 21.66 | |||||||
| 5.01 | |||||||
| 4.28 | |||||||
| 4.69% | |||||||
| $5.68 | |||||||
| $14.87 | |||||||
| 2.34% | |||||||
| Merck & Co Inc | |||||||
| 144.24 | |||||||
| 8.15 | |||||||
| 5.38 | |||||||
| 12.22% | |||||||
| $6.96 | |||||||
| $12.23 | |||||||
| 8.89% | |||||||
| AstraZeneca PLC | |||||||
| 38.61 | |||||||
| 6.47 | |||||||
| 5.13 | |||||||
| 5.69% | |||||||
| $4.47 | |||||||
| $10.46 | |||||||
| 16.55% | |||||||
| Novartis AG | |||||||
| 24.22 | |||||||
| 5.48 | |||||||
| 4.63 | |||||||
| 6.23% | |||||||
| $4.66 | |||||||
| $9.02 | |||||||
| 9.71% | |||||||
| Zoetis Inc | |||||||
| 34 | |||||||
| 15.92 | |||||||
| 9.31 | |||||||
| 11.91% | |||||||
| $0.93 | |||||||
| $1.55 | |||||||
| 9.5% | |||||||
| GSK PLC | |||||||
| 14 | |||||||
| 4.49 | |||||||
| 2.04 | |||||||
| 7.69% | |||||||
| $2.07 | |||||||
| $5.39 | |||||||
| 5.93% | |||||||
| Takeda Pharmaceutical Co Ltd | |||||||
| 45.23 | |||||||
| 0.89 | |||||||
| 1.53 | |||||||
| -0.04% | |||||||
| $86.09 | |||||||
| $668.37 | |||||||
| 9.91% | |||||||
| Dr Reddy's Laboratories Ltd | |||||||
| 18.83 | |||||||
| 3.73 | |||||||
| 3.76 | |||||||
| 4.77% | |||||||
| $20.32 | |||||||
| $41.48 | |||||||
| 12.49% | |||||||
| Jazz Pharmaceuticals PLC | |||||||
| 22.17 | |||||||
| 1.83 | |||||||
| 1.93 | |||||||
| -0.39% | |||||||
| $0.23 | |||||||
| $0.81 | |||||||
| 1.03% | |||||||
| Prestige Consumer Healthcare Inc | |||||||
| 16.70 | |||||||
| 2.10 | |||||||
| 3.10 | |||||||
| 3.04% | |||||||
| $0.09 | |||||||
| $0.15 | |||||||
| -3.11% | |||||||
| Corcept Therapeutics Inc | |||||||
| 30.53 | |||||||
| 6.09 | |||||||
| 6.76 | |||||||
| 5.22% | |||||||
| $0.03 | |||||||
| $0.14 | |||||||
| 38.95% | |||||||
| Average | |||||||
| 38.4 | |||||||
| 8.79 | |||||||
| 5.53 | |||||||
| 7.15% | |||||||
| $14.04 | |||||||
| $68.33 | |||||||
| 11.22% |